Nick Beaumont

Peggy Westlotorn

Richard Harrison

Rachael Burroughs

Yiannis Kiachopoulos

Anna Tzani

Danai Mavreli

Noelle Baquiche

Angeliki Andrianopoulou

Magdalena Sommenvik

Artur Saudabayev

It has been well documented that only 1 out of 10 compounds that enter clinical
trials makes it to market¹. That is an astonishing 90%...

Why poor target validation is costing pharmaceutical businesses millions

It is widely recognized that the Scientific Method is fundamental for
discovering new medicines. We’re all familiar with the process: a...

How AI is redefining hypothesis generation in pharma research

Every month we process more than 100,000 scientific documents.
New knowledge is emerging every months across thousands of scientific disciplines

Knowledge emergence - what we learn from 100K monthly publications

Having an understanding of how the world ticks is at the core of developing our hypotheses. We are connecting the dots from millions of documents into causal knowledge graphs.

Building a causal model of the world

Point of View

Featured article

Why poor target validation is costing pharmaceutical businesses millions

Posts listed under Point of View

Sign up for Causaly newsletter